Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Do age, fitness, and concomitant medications influence management and outcomes of patients with CLL treated with ibrutinib?
Tedeschi A, Frustaci AM, Mauro FR, Chiarenza A, Coscia M, Ciolli S, Reda G, Laurenti L, Varettoni M, Murru R, Baratè C, Sportoletti P, Greco A, Borella C, Rossi V, Deodato M, Biagi A, Zamprogna G, Pelle AC, Lapietra G, Vitale C, Morelli F, Cassin R, Fresa A, Cavalloni C, Postorino M, Ielo C, Cairoli R, Di Raimondo F, Montillo M, Del Poeta G. Tedeschi A, et al. Among authors: ielo c. Blood Adv. 2021 Dec 28;5(24):5490-5500. doi: 10.1182/bloodadvances.2021004824. Blood Adv. 2021. PMID: 34525181 Free PMC article.
Prognostic Impact and Risk Factors of Infections in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib.
Mauro FR, Giannarelli D, Visentin A, Reda G, Sportoletti P, Frustaci AM, Chiarenza A, Ciolli S, Vitale C, Laurenti L, De Paoli L, Murru R, Gentile M, Rigolin GM, Levato L, Giordano A, Del Poeta G, Stelitano C, Ielo C, Noto A, Guarente V, Molica S, Coscia M, Tedeschi A, Gaidano G, Cuneo A, Foà R, Martelli M, Girmenia C, Gentile G, Trentin L. Mauro FR, et al. Among authors: ielo c. Cancers (Basel). 2021 Jun 29;13(13):3240. doi: 10.3390/cancers13133240. Cancers (Basel). 2021. PMID: 34209515 Free PMC article.
Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three-factor model.
Molica S, Giannarelli D, Visentin A, Reda G, Sportoletti P, Frustaci AM, Chiarenza A, Ciolli S, Vitale C, Laurenti L, De Paoli L, Murru R, Gentile M, Moia R, Rigolin GM, Levato L, Giordano A, Del Poeta G, Stelitano C, Deodato M, Ielo C, Noto A, Guarente V, Coscia M, Tedeschi A, Gaidano G, Cuneo A, Foa' R, Trentin L, Mauro FR. Molica S, et al. Among authors: ielo c. Am J Hematol. 2022 May;97(5):E176-E180. doi: 10.1002/ajh.26502. Epub 2022 Feb 25. Am J Hematol. 2022. PMID: 35170793 Free article. No abstract available.
Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study.
Innocenti I, Reda G, Visentin A, Coscia M, Motta M, Murru R, Moia R, Gentile M, Pennese E, Quaglia FM, Albano F, Cassin R, Deodato M, Ielo C, Frustaci AM, Piciocchi A, Rughini A, Arena V, Di Sevo D, Tomasso A, Autore F, Del Poeta G, Scarfò L, Mauro FR, Tedeschi A, Trentin L, Pompili M, Foà R, Ghia P, Cuneo A, Laurenti L. Innocenti I, et al. Among authors: ielo c. Haematologica. 2022 Jun 1;107(6):1470-1473. doi: 10.3324/haematol.2021.280325. Haematologica. 2022. PMID: 35199505 Free PMC article. No abstract available.
Utility of procalcitonin and C-reactive protein as predictors of Gram-negative bacteremia in febrile hematological outpatients.
Jabbour JP, Ciotti G, Maestrini G, Brescini M, Lisi C, Ielo C, La Pietra G, Luise C, Riemma C, Breccia M, Brunetti GA, Carmosino I, Latagliata R, Morano GS, Martelli M, Girmenia C. Jabbour JP, et al. Among authors: ielo c. Support Care Cancer. 2022 May;30(5):4303-4314. doi: 10.1007/s00520-021-06782-w. Epub 2022 Jan 28. Support Care Cancer. 2022. PMID: 35088150
Systemic mastocytosis: 2023 update on diagnosis and management in adults.
Costa A, Scalzulli E, Carmosino I, Capriata M, Ielo C, Masucci C, Passucci M, Martelli M, Breccia M. Costa A, et al. Among authors: ielo c. Expert Opin Emerg Drugs. 2023 Dec;28(3):153-165. doi: 10.1080/14728214.2023.2221028. Epub 2023 Jun 6. Expert Opin Emerg Drugs. 2023. PMID: 37256917 Review.
Case Report: Infectious prophylaxis in hematological malignancies.
Passucci M, Masucci C, Paoletti F, Ielo C, Costa A, Carmosino I, Scalzulli E, Martelli M, Gentile G, Breccia M. Passucci M, et al. Among authors: ielo c. Front Oncol. 2023 May 1;13:1163175. doi: 10.3389/fonc.2023.1163175. eCollection 2023. Front Oncol. 2023. PMID: 37197426 Free PMC article.
SARS-CoV-2 vaccination in patients with paroxysmal nocturnal hemoglobinuria: An Italian multicenter survey.
Giannotta JA, Fattizzo B, Bortolotti M, Girmenia C, Ielo C, Metafuni E, Visentin A, Apolito V, Lucchesi A, Giai V, Beggiato E, Di Bona E, Giglio F, Sica S, Iori AP, Barcellini W. Giannotta JA, et al. Among authors: ielo c. Am J Hematol. 2022 Jul;97(7):E229-E232. doi: 10.1002/ajh.26545. Epub 2022 Mar 26. Am J Hematol. 2022. PMID: 35319125 Free PMC article. No abstract available.
18 results